SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Donald K. Ingram, George S. Roth, Calorie restriction mimetics: Can you have your cake and eat it, too?, Ageing Research Reviews, 2015, 20, 46

    CrossRef

  2. 2
    B. J. Morris, T. A. Donlon, Q. He, J. S. Grove, K. H. Masaki, A. Elliott, D. C. Willcox, R. Allsopp, B. J. Willcox, Genetic Analysis of TOR Complex Gene Variation With Human Longevity: A Nested Case-Control Study of American Men of Japanese Ancestry, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2015, 70, 2, 133

    CrossRef

  3. 3
    Douglas R. Seals, Jamie N. Justice, Thomas J. LaRocca, Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity, The Journal of Physiology, 2015, 593, 10
  4. 4
    Ellen K. Quarles, Dao-Fu Dai, Autumn Tocchi, Nathan Basisty, Lemuel Gitari, Peter S. Rabinovitch, Quality control systems in cardiac aging, Ageing Research Reviews, 2015,

    CrossRef

  5. 5
    Katherine H. Schreiber, Denise Ortiz, Emmeline C. Academia, Arieanna C. Anies, Chen-Yu Liao, Brian K. Kennedy, Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins, Aging Cell, 2015, 14, 2
  6. 6
    Dao-Fu Dai, Pabalu P. Karunadharma, Ying A. Chiao, Nathan Basisty, David Crispin, Edward J. Hsieh, Tony Chen, Haiwei Gu, Danijel Djukovic, Daniel Raftery, Richard P. Beyer, Michael J. MacCoss, Peter S. Rabinovitch, Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart, Aging Cell, 2014, 13, 3
  7. 7
    Sophia N. Mowla, Eric W.-F. Lam, Parmjit S. Jat, Cellular senescence and aging: the role of B-MYB, Aging Cell, 2014, 13, 5
  8. 8
    Olga V Leontieva, Geraldine M Paszkiewicz, Mikhail V Blagosklonny, Comparison of rapamycin schedules in mice on high-fat diet, Cell Cycle, 2014, 13, 21, 3350

    CrossRef

  9. 9
    Brian K. Kennedy, Juniper K. Pennypacker, Drugs that modulate aging: the promising yet difficult path ahead, Translational Research, 2014, 163, 5, 456

    CrossRef

  10. 10
    M V Blagosklonny, Koschei the immortal and anti-aging drugs, Cell Death and Disease, 2014, 5, 12, e1552

    CrossRef

  11. 11
    Dan Ehninger, Frauke Neff, Kan Xie, Longevity, aging and rapamycin, Cellular and Molecular Life Sciences, 2014, 71, 22, 4325

    CrossRef

  12. 12
    J. B. Mannick, G. Del Giudice, M. Lattanzi, N. M. Valiante, J. Praestgaard, B. Huang, M. A. Lonetto, H. T. Maecker, J. Kovarik, S. Carson, D. J. Glass, L. B. Klickstein, mTOR inhibition improves immune function in the elderly, Science Translational Medicine, 2014, 6, 268, 268ra179

    CrossRef

  13. 13
    Yoshiyuki Ikeda, Sebastiano Sciarretta, Narayani Nagarajan, Speranza Rubattu, Massimo Volpe, Giacomo Frati, Junichi Sadoshima, New Insights into the Role of Mitochondrial Dynamics and Autophagy during Oxidative Stress and Aging in the Heart, Oxidative Medicine and Cellular Longevity, 2014, 2014, 1

    CrossRef

  14. 14
    Matt Kaeberlein, Rapamycin and Ageing: When, for How Long, and How Much?, Journal of Genetics and Genomics, 2014, 41, 9, 459

    CrossRef

  15. 15
    Richard A. Miller, David E. Harrison, Clinton M. Astle, Elizabeth Fernandez, Kevin Flurkey, Melissa Han, Martin A. Javors, Xinna Li, Nancy L. Nadon, James F. Nelson, Scott Pletcher, Adam B. Salmon, Zelton Dave Sharp, Sabrina Van Roekel, Lynn Winkleman, Randy Strong, Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction, Aging Cell, 2014, 13, 3
  16. 16
    Sailay Siddiqi, Mark A. Sussman, The Heart: Mostly Postmitotic or Mostly Premitotic? Myocyte Cell Cycle, Senescence, and Quiescence, Canadian Journal of Cardiology, 2014, 30, 11, 1270

    CrossRef

  17. 17
    Benjamin F. Miller, Joshua C. Drake, Bradley Naylor, John C. Price, Karyn L. Hamilton, The measurement of protein synthesis for assessing proteostasis in studies of slowed aging, Ageing Research Reviews, 2014, 18, 106

    CrossRef

  18. 18
    Olga V. Leontieva, Geraldine M. Paszkiewicz, Mikhail V. Blagosklonny, Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet, Aging Cell, 2014, 13, 4
  19. 19
    Chen-Yu Liao, Brian K. Kennedy, Mouse Models of The Nuclear Envelopathies and Related Diseases, 2014,

    CrossRef

  20. 20
    Mikhail V Blagosklonny, Aging is not programmed, Cell Cycle, 2013, 12, 24, 3736

    CrossRef

  21. 21
    Sailay Siddiqi, Mark A. Sussman, Cardiac Hegemony of Senescence, Current Translational Geriatrics and Experimental Gerontology Reports, 2013, 2, 4, 247

    CrossRef

  22. 22
    Olga V. Leontieva, Mikhail V. Blagosklonny, CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion, Cell Cycle, 2013, 12, 18, 3063

    CrossRef

  23. 23
    Olga V Leontieva, Liliya R Novototskaya, Geraldine M Paszkiewicz, Elena A Komarova, Andrei V Gudkov, Mikhail V Blagosklonny, Dysregulation of the mTOR pathway in p53-deficient mice, Cancer Biology & Therapy, 2013, 14, 12, 1182

    CrossRef

  24. 24
    Mikhail V Blagosklonny, Immunosuppressants in cancer prevention and therapy, OncoImmunology, 2013, 2, 12, e26961

    CrossRef

  25. 25
    S. C. Johnson, G. M. Martin, P. S. Rabinovitch, M. Kaeberlein, Preserving Youth: Does Rapamycin Deliver?, Science Translational Medicine, 2013, 5, 211, 211fs40

    CrossRef

  26. 26
    Mikhail V Blagosklonny, Selective anti-cancer agents as anti-aging drugs, Cancer Biology & Therapy, 2013, 14, 12, 1092

    CrossRef

  27. 27
    M V Blagosklonny, TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists, Cell Death and Disease, 2013, 4, 12, e964

    CrossRef